| Literature DB >> 28469040 |
Bradley N Smith1, Simon D Topp1, Claudia Fallini2, Hideki Shibata3, Han-Jou Chen1, Claire Troakes1, Andrew King1, Nicola Ticozzi4,5, Kevin P Kenna2, Athina Soragia-Gkazi1, Jack W Miller1, Akane Sato3, Diana Marques Dias1, Maryangel Jeon2, Caroline Vance1, Chun Hao Wong1, Martina de Majo1, Wejdan Kattuah1, Jacqueline C Mitchell1, Emma L Scotter6, Nicholas W Parkin7, Peter C Sapp2, Matthew Nolan1, Peter J Nestor8, Michael Simpson9, Michael Weale9, Monkel Lek10,11, Frank Baas12, J M Vianney de Jong12, Anneloor L M A Ten Asbroek12, Alberto Garcia Redondo13, Jesús Esteban-Pérez13, Cinzia Tiloca4,5, Federico Verde4,5, Stefano Duga14,15, Nigel Leigh16, Hardev Pall17, Karen E Morrison18, Ammar Al-Chalabi1, Pamela J Shaw19, Janine Kirby19, Martin R Turner20, Kevin Talbot20, Orla Hardiman21, Jonathan D Glass22, Jacqueline De Belleroche23, Masatoshi Maki3, Stephen E Moss24, Christopher Miller1, Cinzia Gellera25, Antonia Ratti4,5, Safa Al-Sarraj1, Robert H Brown2, Vincenzo Silani4,5, John E Landers2, Christopher E Shaw26.
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder. We screened 751 familial ALS patient whole-exome sequences and identified six mutations including p.D40G in the ANXA11 gene in 13 individuals. The p.D40G mutation was absent from 70,000 control whole-exome sequences. This mutation segregated with disease in two kindreds and was present in another two unrelated cases (P = 0.0102), and all mutation carriers shared a common founder haplotype. Annexin A11-positive protein aggregates were abundant in spinal cord motor neurons and hippocampal neuronal axons in an ALS patient carrying the p.D40G mutation. Transfected human embryonic kidney cells expressing ANXA11 with the p.D40G mutation and other N-terminal mutations showed altered binding to calcyclin, and the p.R235Q mutant protein formed insoluble aggregates. We conclude that mutations in ANXA11 are associated with ALS and implicate defective intracellular protein trafficking in disease pathogenesis.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28469040 PMCID: PMC6599403 DOI: 10.1126/scitranslmed.aad9157
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 19.319